FMP

FMP

Enter
API Tools
API DocumentationAPI ViewerAPI DocumentationLegacyAPI ViewerLegacy
Pricing
Blog
How To
Education
Index ArticlesForexFinancial RatiosCryptoFinancial AnalysisOther
Market NewsDiscounted Cash FlowDeveloper
Screener
Most Searched StocksForeign Exchange RatesCryptocurrenciesMarket IndexesMarket Top GainersMarket Top LosersMarket Highest VolumeSector Performance
Extras
Resources
Formula Methodologies
Financial FormulasParsing StatementsDCF FormulaPiotroski ScoreOwner EarningsRecommendations Formula
Excel/Sheets Add-on
Excel Add-onGoogle Sheet Add-on
API Updates
ChangelogAPI StatusCycle Times
CareersAffiliate ProgramFAQs
Sign InSign Up

GMTX - Gemini Therapeutics,...

photo-url-https://images.financialmodelingprep.com/symbol/GMTX.png

Gemini Therapeutics, Inc.

GMTX

NASDAQ

Inactive Equity

Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD). Its lead candidate is GEM103, a recombinant form of the human complement factor H protein to treat dry AMD patients. The company also develops GEM307 for treatment of systemic diseases. Gemini Therapeutics, Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.

1.35 USD

0 (0%)

OverviewProfileFinancial StatementsFinancial RatiosChartAnalysisNewsCorporate ActionsDCF

Valuation Date:

Dec 30, 2022 12:00 AM

Share Price on Valuation Date

$1.35

Stock Beta

0

Shares Outstanding

18882800

FMP

FMP

FMP

HomeTerms of ServicePrivacy PolicyBlogCareersFAQsContact Us

API

DocumentationPricingFormulasMarket Indexes
Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep